Indo Us Bio-Tech Share Price | Indo Us Bio-Tech Stock Screener
INDOUS
Agricultural Products
Share Price NSE
₹84.98
▼
-1.95 (-2.24%)
Share Price BSE
₹85.01
▼
-1.12 (-1.30%)
As of July 24, 2026, the Indo Us Bio-Tech share price (NSE: INDOUS) is ₹84.98 on NSE and ₹85.01 on BSE, down 2.24% from the previous close, with shares trading between ₹84.60 and ₹88.80, and a 52-week range of ₹84.98–₹179.35.
Analyse INDOUS stock price history and track historical price performance.
Use the Indo Us Bio-Tech stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Indo Us Bio-Tech Market Cap
₹172.09 Cr.
INDOUS P/E Ratio (TTM)
-
Indo Us Bio-Tech P/B Ratio
3.91
EPS (TTM)
₹8.27
Dividend Yield
-
Debt to Equity
0.41
INDOUS 52 Week High
₹179.35
Indo Us Bio-Tech 52 Week Low
₹84.98
Operating Margin
-
Profit Margin
-
INDOUS Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹56.00
Total Equity
₹39.00
Indo Us Bio-Tech Share Price Chart
Screen Indo Us Bio-Tech share price with an interactive chart. Analyse INDOUS price trends and volatility across different timeframes.
Indo Us Bio-Tech Company Profile - Fundamental Screener
Screen Indo Us Bio-Tech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for INDOUS shares.
Sector
FMCG
Industry
Agricultural Products
Sub-Sector
Agricultural Products
Segment
E
ISIN
INE250Z01010
Indo Us Bio-Tech Balance Sheet Screener
Screen INDOUS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2022 | 2021 | 2020 |
|---|---|---|---|
| Assets | |||
| Total Assets | 56 | 44 | 35 |
| Current Assets | 47 | 38 | 32 |
| Fixed Assets | 6 | 2 | 1 |
| Liabilities | |||
| Total Liabilities | 0 | 0 | 0 |
| Current Liabilities | 5 | 4 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 |
| Shareholders' Equity | |||
| Total Equity | 39 | 21 | 16 |
| Share Capital | 9 | 6 | 6 |
| Reserves & Surplus | 29 | 15 | 10 |
Indo Us Bio-Tech Income Statement Screener - Profit & Revenue Analysis
Screen Indo Us Bio-Tech income statement and profit fundamentals.
Analyze INDOUS quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Indo Us Bio-Tech share price evaluation.
| Item | None-None | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|
| Revenue | 0 | 50 | 40 | 40 |
| Expenses | 0 | 43 | 35 | 36 |
| EBITDA | 0 | 7 | 5 | 4 |
| Operating Profit % | 0.00% | 14.00% | 13.00% | 10.00% |
| Depreciation | 0 | 1 | 0 | 0 |
| Interest | 0 | 1 | 1 | 1 |
| Profit Before Tax | 0 | 5 | 4 | 3 |
| Tax | 0 | 0 | -1 | 0 |
| Net Profit | 0 | 5 | 5 | 3 |
| EPS | 0.00 | 8.27 | 8.07 | 4.18 |
Indo Us Bio-Tech Cash Flow Screener - Liquidity Fundamentals
Screen INDOUS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2022-March | 2021-March | 2020-March |
|---|---|---|---|
| Operating Activities | 3 | 0 | -1 |
| Investing Activities | -5 | -2 | -1 |
| Financing Activities | 3 | 2 | 2 |
| Net Cash Flow | 0 | 0 | 0 |
Indo Us Bio-Tech Shareholding Pattern Screener
See Indo Us Bio-Tech shareholding pattern with promoter, FII, and DII holdings.
Check Indo Us Bio-Tech promoter holding and ownership changes for INDOUS on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 68.29% | 68.29% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% |
| FII Holding | 0.18% | 0.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 24.46% | 24.51% | 24.34% | 24.36% | 24.14% | 23.69% | 24.43% | 24.42% |
| Other Holding | 7.07% | 7.19% | 5.49% | 5.47% | 5.69% | 6.13% | 5.40% | 5.40% |
| Shareholder Count | 4,531 | 4,690 | 2,780 | 3,112 | 4,130 | 4,738 | 1,183 | 1,133 |
Indo Us Bio-Tech Share Dividend Screener - Share Yield Analysis
Check Indo Us Bio-Tech dividend history with payout and yield data.
View Indo Us Bio-Tech dividend details including ex-dates and amounts for INDOUS stock.
Indo Us Bio-Tech Stock Index Membership
See which indices include Indo Us Bio-Tech stock.
Check INDOUS index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Indo Us Bio-Tech Market Events Screener - Corporate Actions
Get Indo Us Bio-Tech corporate actions including splits, bonuses, and buybacks.
Check Indo Us Bio-Tech stock events that may affect INDOUS share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | -1.72% |
| 2026-01-21 | 2026-01-21 | Quarterly Result Announcement | NA | -5.09% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -4.41% |
| 2025-09-30 | 2025-09-30 | Annual General Meeting | NA | -11.62% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -3.16% |
| 2025-05-26 | 2025-05-26 | Quarterly Result Announcement | NA | -0.40% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | -1.51% |
| 2024-12-03 | 2024-12-03 | Dividend | ₹ 0.25 /share | 22.71% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -7.20% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | -11.18% |
| 2023-09-30 | 2023-09-30 | Annual General Meeting | NA | 3.60% |
| 2023-08-29 | 2023-08-29 | Bonus | 1:1 | 37.96% |
| 2021-11-29 | Bonus | 1:5 | - | |
| 2021-10-28 | 2021-10-29 | Dividend | ₹ 0.25 /share | -7.95% |
| 2018-01-11 | 2018-01-11 | Change Of Name | NA | - |
Indo Us Bio-Tech Competitors Screener - Peer Comparison
Screen INDOUS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| LT Foods | 13,196 | 21.40 | 10,946 | 24.81% | 613 | 46.42 |
| KRBL | 8,127 | 12.56 | 6,098 | 7.83% | 641 | 42.58 |
| Gujarat Ambuja Exports | 6,541 | 21.69 | 5,729 | 22.01% | 311 | 27.76 |
| Kaveri Seed Company | 4,462 | 14.69 | 1,395 | 11.46% | 290 | 47.32 |
| Trualt Bioenergy | 3,597 | 37.20 | 1,728 | -12.24% | 127 | 30.57 |
| Sanstar | 1,964 | 32.70 | 1,082 | -10.58% | 67 | 41.14 |
| Amir Chand Jagdish Kumar (Exports) | 1,927 | 19.52 | 2,287 | 14.13% | 103 | 68.80 |
| GRM Overseas | 1,893 | 25.33 | 1,769 | 28.74% | 76 | 32.13 |
| Chaman Lal Setia Exports | 1,387 | 11.55 | 1,504 | 10.16% | 103 | 46.61 |
| Gulshan Polyols | 1,128 | 26.40 | 2,025 | 45.63% | 25 | 41.90 |
Indo Us Bio-Tech Company Announcements - News Screener
Screen INDOUS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-19 | Revised Outcome Of The Board Meeting Held On 10 July 2026. Reconstitution Of Committees. | - |
| 2026-07-19 | Revised: Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations 2015. Ref.: Mail From [email protected] On 13.07.2026 Subject: Resignation Of Statutory Auditor And Appointment Of New Statutory Aud | - |
| 2026-07-10 | Board Meeting Outcome for Change In Composition Of Committees Of The Board. Outcome Of Board Meeting Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-07-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-04 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-07-03 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 3Rd July 2026. | - |
| 2026-06-29 | Closure of Trading Window | - |
| 2026-06-17 | Revised: Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations 2015. Ref.: Mail From [email protected] At 11:00?AM On 17.06.2026 Subject: Resignation Of Statutory Auditor And Appointment O | - |
| 2026-06-16 | Announcement Under Regulation 30 Of SEBI LODR (Resignation Of Existing Statutory Auditor Appointment Of New Statutory Auditor Resignation Of Existing Internal Auditor And Appointment Of New Internal Auditor) | - |
| 2026-06-16 | Board Meeting Outcome for Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Resignation And Appointment Of Statutory Auditor And Internal Auditor. | - |
| 2026-05-30 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-29 | Results- Financial Results For March 31 2026 | - |
| 2026-05-29 | Board Meeting Outcome for Outcome Of Board Meeting Submission Of Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March 2026. | - |
| 2026-05-28 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-21 | Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-04-30 | Non-Applicability Of Large Corporate Criteria As Per SEBI Circular Dated November 26 2018 | - |
| 2026-04-22 | Announcement under Regulation 30 (LODR)-Resignation of Director | - |
| 2026-04-22 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-04-21 | Resignation Of Mrs. Nehaben Sachinbhai Patel (DIN: 09263180) From The Post Of Independent Director Of The Company. | - |